Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Aug;9(8):576-86.
doi: 10.1038/nrc2683.

CYP2D6 and tamoxifen: DNA matters in breast cancer

Janelle M Hoskins  1 , Lisa A Carey, Howard L McLeod
Affiliations
Review

CYP2D6 and tamoxifen: DNA matters in breast cancer

Janelle M Hoskins et al. Nat Rev Cancer. 2009 Aug.

Abstract

Tamoxifen is the most widely used anti-oestrogen for the treatment of hormone-dependent breast cancer. The pharmacological activity of tamoxifen is dependent on its conversion by the hepatic drug-metabolizing enzyme cytochrome P450 2D6 (CYP2D6) to its abundant metabolite, endoxifen. Patients with reduced CYP2D6 activity, as a result of either their genotype or induction by the co-administration of drugs that inhibit CYP2D6 function, produce little endoxifen and seem to derive inferior therapeutic benefit from tamoxifen. Here we review the existing data that relate CYP2D6 genotypes to response to tamoxifen and discuss whether the analysis of the CYP2D6 genotype might be an early example of a pharmacogenetic tool for optimizing breast cancer therapy.

PubMed Disclaimer

Comment in

References

    1. Pharmacogenomics. 2002 Mar;3(2):229-43 - PubMed
    1. Pharmacogenetics. 2001 Jul;11(5):417-27 - PubMed
    1. Pharmacogenomics J. 2005;5(1):6-13 - PubMed
    1. J Natl Cancer Inst. 2005 Jan 5;97(1):30-9 - PubMed
    1. Pharmacol Ther. 2007 Dec;116(3):496-526 - PubMed

Publication types

MeSH terms

LinkOut - more resources